Characteristics of adult patients with ...
Type de document :
Article dans une revue scientifique: Article original
PMID :
URL permanente :
Titre :
Characteristics of adult patients with chronic intestinal failure due to short bowel syndrome: An international multicenter survey.
Auteur(s) :
Pironi, L. [Auteur]
Steiger, E. [Auteur]
Joly, Francisca [Auteur]
Hôpital Beaujon [AP-HP]
Jeppesen, P. B. [Auteur]
Wanten, G. [Auteur]
Sasdelli, A. S. [Auteur]
Chambrier, Cécile [Auteur]
Centre Hospitalier Lyon Sud [CHU - HCL] [CHLS]
Aimasso, U. [Auteur]
Mundi, M. S. [Auteur]
Szczepanek, K. [Auteur]
Jukes, A. [Auteur]
Theilla, M. [Auteur]
Kunecki, M. [Auteur]
Daniels, J. [Auteur]
Serlie, M. [Auteur]
Poullenot, Florian [Auteur]
Hôpital Haut-Lévêque [CHU Bordeaux]
Cooper, S. C. [Auteur]
Rasmussen, H. H. [Auteur]
Compher, C. [Auteur]
Seguy, David [Auteur]
Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Crivelli, A. [Auteur]
Santarpia, L. [Auteur]
Guglielmi, F. W. [Auteur]
Kozjek, N. R. [Auteur]
Schneider, Stéphane M [Auteur]
Centre Hospitalier Universitaire de Nice [CHU Nice]
Université Côte d'Azur [UniCA]
Ellegard, L. [Auteur]
Thibault, Ronan [Auteur]
Nutrition, Métabolismes et Cancer [NuMeCan]
Centre Hospitalier Universitaire [Rennes]
Université de Rennes [UR]
Matras, P. [Auteur]
Matysiak, K. [Auteur]
Van Gossum, A. [Auteur]
Forbes, A. [Auteur]
Wyer, N. [Auteur]
Taus, M. [Auteur]
Virgili, N. M. [Auteur]
O'callaghan, M. [Auteur]
Chapman, B. [Auteur]
Osland, E. [Auteur]
Cuerda, C. [Auteur]
Udvarhelyi, G. [Auteur]
Jones, L. [Auteur]
Won Lee, A. D. [Auteur]
Masconale, L. [Auteur]
Orlandoni, P. [Auteur]
Spaggiari, C. [Auteur]
Díez, M. B. [Auteur]
Doitchinova-Simeonova, M. [Auteur]
Serralde-Zúñiga, A. E. [Auteur]
Olveira, G. [Auteur]
Krznaric, Z. [Auteur]
Czako, L. [Auteur]
Kekstas, G. [Auteur]
Sanz-Paris, A. [Auteur]
Jáuregui, M. E. P. [Auteur]
Murillo, A. Z. [Auteur]
Schafer, E. [Auteur]
Arends, J. [Auteur]
Suárez-Llanos, J. P. [Auteur]
Youssef, N. N. [Auteur]
Brillanti, G. [Auteur]
Nardi, E. [Auteur]
Lal, S. [Auteur]
Steiger, E. [Auteur]
Joly, Francisca [Auteur]
Hôpital Beaujon [AP-HP]
Jeppesen, P. B. [Auteur]
Wanten, G. [Auteur]
Sasdelli, A. S. [Auteur]
Chambrier, Cécile [Auteur]
Centre Hospitalier Lyon Sud [CHU - HCL] [CHLS]
Aimasso, U. [Auteur]
Mundi, M. S. [Auteur]
Szczepanek, K. [Auteur]
Jukes, A. [Auteur]
Theilla, M. [Auteur]
Kunecki, M. [Auteur]
Daniels, J. [Auteur]
Serlie, M. [Auteur]
Poullenot, Florian [Auteur]
Hôpital Haut-Lévêque [CHU Bordeaux]
Cooper, S. C. [Auteur]
Rasmussen, H. H. [Auteur]
Compher, C. [Auteur]
Seguy, David [Auteur]
Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Crivelli, A. [Auteur]
Santarpia, L. [Auteur]
Guglielmi, F. W. [Auteur]
Kozjek, N. R. [Auteur]
Schneider, Stéphane M [Auteur]
Centre Hospitalier Universitaire de Nice [CHU Nice]
Université Côte d'Azur [UniCA]
Ellegard, L. [Auteur]
Thibault, Ronan [Auteur]
Nutrition, Métabolismes et Cancer [NuMeCan]
Centre Hospitalier Universitaire [Rennes]
Université de Rennes [UR]
Matras, P. [Auteur]
Matysiak, K. [Auteur]
Van Gossum, A. [Auteur]
Forbes, A. [Auteur]
Wyer, N. [Auteur]
Taus, M. [Auteur]
Virgili, N. M. [Auteur]
O'callaghan, M. [Auteur]
Chapman, B. [Auteur]
Osland, E. [Auteur]
Cuerda, C. [Auteur]
Udvarhelyi, G. [Auteur]
Jones, L. [Auteur]
Won Lee, A. D. [Auteur]
Masconale, L. [Auteur]
Orlandoni, P. [Auteur]
Spaggiari, C. [Auteur]
Díez, M. B. [Auteur]
Doitchinova-Simeonova, M. [Auteur]
Serralde-Zúñiga, A. E. [Auteur]
Olveira, G. [Auteur]
Krznaric, Z. [Auteur]
Czako, L. [Auteur]
Kekstas, G. [Auteur]
Sanz-Paris, A. [Auteur]
Jáuregui, M. E. P. [Auteur]
Murillo, A. Z. [Auteur]
Schafer, E. [Auteur]
Arends, J. [Auteur]
Suárez-Llanos, J. P. [Auteur]
Youssef, N. N. [Auteur]
Brillanti, G. [Auteur]
Nardi, E. [Auteur]
Lal, S. [Auteur]
Titre de la revue :
Clinical Nutrition
Nom court de la revue :
Clin Nutr ESPEN
Numéro :
45
Pagination :
433-441
Date de publication :
2021-10-10
ISSN :
2405-4577
Mot(s)-clé(s) en anglais :
Short bowel syndrome
Intestinal failure
Intravenous supplementation
Home parenteral nutrition
Epidemiology
Intestinal failure
Intravenous supplementation
Home parenteral nutrition
Epidemiology
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
Background and aims
The case-mix of patients with intestinal failure due to short bowel syndrome (SBS-IF) can differ among centres and may also be affected by the timeframe of data collection. Therefore, the ESPEN ...
Lire la suite >Background and aims The case-mix of patients with intestinal failure due to short bowel syndrome (SBS-IF) can differ among centres and may also be affected by the timeframe of data collection. Therefore, the ESPEN international multicenter cross-sectional survey was analyzed to compare the characteristics of SBS-IF cohorts collected within the same timeframe in different countries. Methods The study included 1880 adult SBS-IF patients collected in 2015 by 65 centres from 22 countries. The demographic, nutritional, SBS type (end jejunostomy, SBS-J; jejuno-colic anastomosis, SBS-JC; jejunoileal anastomosis with an intact colon and ileocecal valve, SBS-JIC), underlying disease and intravenous supplementation (IVS) characteristics were analyzed. IVS was classified as fluid and electrolyte alone (FE) or parenteral nutrition admixture (PN). The mean daily IVS volume, calculated on a weekly basis, was categorized as <1, 1–2, 2–3 and >3 L/day. Results In the entire group: 60.7% were females and SBS-J comprised 60% of cases, while mesenteric ischaemia (MI) and Crohn’ disease (CD) were the main underlying diseases. IVS dependency was longer than 3 years in around 50% of cases; IVS was infused ≥5 days/week in 75% and FE in 10% of cases. Within the SBS-IF cohort: CD was twice and thrice more frequent in SBS-J than SBS-JC and SBS-JIC, respectively, while MI was more frequent in SBS-JC and SBS-JIC. Within countries: SBS-J represented 75% or more of patients in UK and Denmark and 50-60% in the other countries, except Poland where SBS-JC prevailed. CD was the main underlying disease in UK, USA, Denmark and The Netherlands, while MI prevailed in France, Italy and Poland. Conclusions SBS-IF type is primarily determined by the underlying disease, with significant variation between countries. These novel data will be useful for planning and managing both clinical activity and research studies on SBS.Lire moins >
Lire la suite >Background and aims The case-mix of patients with intestinal failure due to short bowel syndrome (SBS-IF) can differ among centres and may also be affected by the timeframe of data collection. Therefore, the ESPEN international multicenter cross-sectional survey was analyzed to compare the characteristics of SBS-IF cohorts collected within the same timeframe in different countries. Methods The study included 1880 adult SBS-IF patients collected in 2015 by 65 centres from 22 countries. The demographic, nutritional, SBS type (end jejunostomy, SBS-J; jejuno-colic anastomosis, SBS-JC; jejunoileal anastomosis with an intact colon and ileocecal valve, SBS-JIC), underlying disease and intravenous supplementation (IVS) characteristics were analyzed. IVS was classified as fluid and electrolyte alone (FE) or parenteral nutrition admixture (PN). The mean daily IVS volume, calculated on a weekly basis, was categorized as <1, 1–2, 2–3 and >3 L/day. Results In the entire group: 60.7% were females and SBS-J comprised 60% of cases, while mesenteric ischaemia (MI) and Crohn’ disease (CD) were the main underlying diseases. IVS dependency was longer than 3 years in around 50% of cases; IVS was infused ≥5 days/week in 75% and FE in 10% of cases. Within the SBS-IF cohort: CD was twice and thrice more frequent in SBS-J than SBS-JC and SBS-JIC, respectively, while MI was more frequent in SBS-JC and SBS-JIC. Within countries: SBS-J represented 75% or more of patients in UK and Denmark and 50-60% in the other countries, except Poland where SBS-JC prevailed. CD was the main underlying disease in UK, USA, Denmark and The Netherlands, while MI prevailed in France, Italy and Poland. Conclusions SBS-IF type is primarily determined by the underlying disease, with significant variation between countries. These novel data will be useful for planning and managing both clinical activity and research studies on SBS.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
Université de Lille
Inserm
CHU Lille
Inserm
CHU Lille
Date de dépôt :
2024-01-12T05:56:16Z
2024-02-28T15:19:54Z
2024-02-28T15:19:54Z
Fichiers
- document
- Accès libre
- Accéder au document